Clinical Trials Directory

Trials / Unknown

UnknownNCT01410617

The Effect of Prophylactic Hemodialysis on the Morbidity and Mortality of the Patients With Chronic Kidney Disease Stages 3-4 Undergoing Coronary Artery Graft Bypass

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Imam Khomeini Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Coronary artery disease is a major cause of death in patients with renal dysfunction Among patients who undergo coronary artery bypass grafting ,renal dysfunction is known To be a major predictor of in-hospital and remote mortality As little is known about the impact of non-dialysis-dependent renal dysfunction on short and mid term Outcomes following coronary surgery we have decided to investigate the effect of prophylactic Hemodialysis on the mortality and morbidity of the patients with ckd (stage 3,4 ) and compare these Effect with the control group

Conditions

Interventions

TypeNameDescription
PROCEDUREhemodialysis3 sessions hemodialysis before CABG

Timeline

Start date
2011-08-01
Primary completion
2013-09-01
Completion
2013-12-01
First posted
2011-08-05
Last updated
2013-03-27

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT01410617. Inclusion in this directory is not an endorsement.